top of page

News & Articles

Practical Perspectives from an Integrated CDMO. Drug development decisions shape timelines, budgets, and regulatory outcomes. In this section, our scientists share insights drawn from real-world experience across discovery, process chemistry, CMC strategy, analytical development, and stability programs.

Our focus is simple: actionable knowledge that helps biotech and pharmaceutical teams move forward with clarity and confidence.

Latest posts

SmaBio Labs: General Information & Core Services

SmaBio Labs: General Information & Core Services

SmaBio Labs delivers speed and precision for the science of tomorrow.

Analytical Services: Ensuring Quality, Safety, and Efficacy

Analytical Services: Ensuring Quality, Safety, and Efficacy

SmaBio Labs provides comprehensive analytical services to support customers from drug discovery through commercial product release.

Analytical Support for High Potent Drug Development

Analytical Support for High Potent Drug Development

Discover how specialized end-to-end analytical support accelerates the development of High Potent Active Pharmaceutical Ingredients (HPAPIs).

GLP-1 didn’t become a breakthrough overnight.

GLP-1 didn’t become a breakthrough overnight.

In a world where AI can write, design, and code — creativity has become the new intelligence.

Why Small Molecules Still Matter in Drug
Discovery & Therapeutics?

Why Small Molecules Still Matter in Drug
Discovery & Therapeutics?

Despite the rapid rise of biologics, small molecules remain the undisputed powerhouse of modern drug discovery, accounting for ~65% of all novel FDA approvals in 2025.

Medicinal Chemistry Services at SmaBio Labs

Medicinal Chemistry Services at SmaBio Labs

SmaBio Labs offers a comprehensive suite of Medicinal Chemistry services from compound design through to IND filing.

SmaBioLabs product development solutions

SmaBioLabs product development solutions

Explore SmaBio Labs' comprehensive, end-to-end product development solutions.

Speed Vs Cost in Peptides: Choosing the Right Path to Market

Speed Vs Cost in Peptides: Choosing the Right Path to Market

Getting a peptide from idea → clinic → market is a trade‑off between time‑to‑data and unit economics. In practice you’re choosing among SPPS (solid‑phase), LPPS (solution‑phase), or a hybrid (SPPS fragments + solution ligation).

Molecule of the Month: Gabapentin

Molecule of the Month: Gabapentin

Originally developed in the 1970s as a GABA analog for epilepsy, Gabapentin has evolved into a versatile cornerstone of modern multimodal therapy.

668483a55f60986aff7e1ef7_cta-v3-image-la

Subscribe to our weekly newsletter

Stay updated with SmaBio Labs events, insights, and innovations. Subscribe to our newsletter for the latest scientific updates.

bottom of page